Facetten
Zugriff
Einrichtung
Medientyp
- Text 7
Karte
Erscheinungsjahr
Autor/in
- Nooka, Ajay K
- Weisel, Katja 4
- Callander, Natalie 3
- Chari, Ajai 3
- Lonial, Sagar 3
- alle zeigen
Sprache
- Englisch 7
7 Einträge gefunden
-
Carfilzomib 56 mg/m2 twice-weekly in combination with dexamethasone and daratumumab (KdD) versus daratumumab in combination with bortezomib and dexamethasone (DVd): a matching-adjusted indirect treatment comparison
- Weisel, Katja
- Nooka, Ajay K
- Terpos, Evangelos
- Spencer, Andrew
- Goldschmidt, Hartmut
- Dirnberger, Franziska
- DeCosta, Lucy
-
Longer term outcomes with single-agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13-month follow-up from the pivotal DREAMM-2 study
2021 - Forschungsinformationssystem des UKE - frei zugänglich -
Health-related quality of life maintained over time in patients with relapsed or refractory multiple myeloma treated with daratumumab in combination with bortezomib and dexamethasone: results from the phase III CASTOR trial
- Hungria, Vania
- Beksac, Meral
- Weisel, Katja C
- Nooka, Ajay K
- Masszi, Tamas
- Spicka, Ivan
- Munder, Markus
-
Belantamab mafodotin in combination with novel agents in relapsed/refractory multiple myeloma: DREAMM-5 study design
- Nooka, Ajay K
- Weisel, Katja
- van de Donk, Niels Wcj
- Routledge, David
- Otero, Paula Rodriguez
- Song, Kevin
- Quach, Hang
-
Daratumumab-based regimens are highly effective and well tolerated in relapsed or refractory multiple myeloma regardless of patient age: subgroup analysis of the phase 3 CASTOR and POLLUX studies
- Mateos, Maria-Victoria
- Spencer, Andrew
- Nooka, Ajay K
- Pour, Ludek
- Weisel, Katja
- Cavo, Michele
- Laubach, Jacob P
-
-
Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma
- Chari, Ajai
- Vogl, Dan T
- Gavriatopoulou, Maria
- Nooka, Ajay K
- Yee, Andrew J
- Huff, Carol A
- Moreau, Philippe